The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation

Clinical Transplantation

Volumn 29, Issue 2, 2015, Pages 142-148

  Kim, Hyosang ^a   Jeong, Jong Cheol ^b   Yang, Jaeseok ^b   Yang, Won Seok ^a   Ahn, Curie ^b   Han, Duck Jong ^a   Park, Jung Sik ^a   Park, Su Kil ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Cyclosporine; Kidney; Pregnancy; Tacrolimus; Transplantation

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS; CALCINEURIN INHIBITOR;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CESAREAN SECTION; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; VAGINAL DELIVERY; FOLLOW UP; GRAFT REJECTION; MALE; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RETROSPECTIVE STUDY;

ADULT; CALCINEURIN INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84921463918     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12494     Document Type: Article

References (24)

1. Scott LJ, McKeage K, Keam SJ et al. Tacrolimus: a further update of its use in the management of organ transplantation. Drugs 2003: 63: 1247.
2. McKay DB, Josephson MA, Armenti VT et al. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 2005: 5: 1592.
3. Concepcion BP, Schaefer HM. Caring for the pregnant kidney transplant recipient. Clin Transplant 2011: 25: 821.
4. Josephson MA, McKay DB. Pregnancy and kidney transplantation. Semin Nephrol 2011: 31: 100.
5. Cunningham FG. Renal and urinary tract disorder. In: Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY eds. Williams Obstetrics, 23rd edn. New York, NY: McGraw-Hill Medical, 2010: 1033.
6. Sattler M, Guengerich FP, Yun CH et al. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos 1992: 20: 753.
7. Fahr A. Cyclosporin clinical pharmacokinetics. Clin Pharmacokinet 1993: 24: 472.
8. Zheng S, Easterling TR, Umans JG et al. Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit 2012: 34: 660.
9. Hebert MF, Zheng S, Hays K et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation 2013: 95: 908.
10. Burrows L, Knight R, Thomas A et al. Cyclosporine levels during pregnancy. Transplant Proc 1994: 26: 2820.
11. Armenti VT, Ahlswede KM, Ahlswede BA et al. Variables affecting birthweight and graft survival in 197 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1995: 59: 476.
12. Kozlowska-Boszko B, Gaciong Z, Serafinowicz A et al. Cyclosporine A blood concentration during pregnancy in renal allograft recipients. Transpl Int 1998: 11(Suppl 1): S90.
13. Kainz A, Harabacz I, Cowlrick IS et al. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 2000: 70: 1718.
14. Coscia LA, Constantinescu S, Moritz MJ et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transplant 2010: 1: 65.
15. Deshpande NA, James NT, Kucirka LM et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am J Transplant 2011: 11: 2388.
16. Stratta P, Canavese C, Giacchino F et al. Pregnancy in kidney transplantation: satisfactory outcomes and harsh realities. J Nephrol 2003: 16: 792.
17. Davison JM, Dunlop W. Renal hemodynamics and tubular function normal human pregnancy. Kidney Int 1980: 18: 152.
18. Davison JM. The effect of pregnancy on kidney function in renal allograft recipients. Kidney Int 1985: 27: 74.
19. Hebert MF, Easterling TR, Kirby B et al. Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther 2008: 84: 248.
20. Buschur E, Kim C. Guidelines and interventions for obesity during pregnancy. Int J Gynaecol Obstet 2012: 119: 6.
21. Armentl VT, Wilson GA, Radomski JS et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transplant 1999: 1: 111.
22. Lopez V, Martinez D, Vinolo C et al. Pregnancy in kidney transplant recipients: effects on mother and newborn. Transplant Proc 2011: 43: 2177.
23. First MR, Schroeder TJ, Monaco AP et al. Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation subpopulations. Clin Transplant 1996: 10: 55.
24. Jain AB, Shapiro R, Scantlebury VP et al. Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience. Transplantation 2004: 77: 897.